I would like to correct several inaccuracies in your Jan. 31 special report on the Vancouver Stock Exchange (VSE) (“Cracking down in Vancouver”) and, specifically, on Current Technology Corp. (CTC). CTC has developed a treatment for alopecia areata (common baldness), not a cure as the article stated. The completion date of a private placement that raised $3.75 million for CTC was June, 1993, not October, 1993. Of greatest concern, however, is the suggestion that CTC has had trouble “keeping a listing on other markets.” In fact, CTC has been listed on NASDAQ in the United States since June, 1992, and it is a senior listed company on the VSE. I feel that CTC was unfairly included in a sensational story about the VSE, considering that five of the other seven companies mentioned are no longer listed.
Anne Kramer, Chief executive officer, Current Technology Corp., Vancouver
The story you want is part of the Maclean’s Archives. To access it, log in here or sign up for your free 30-day trial.
Experience anything and everything Maclean's has ever published — over 3,500 issues and 150,000 articles, images and advertisements — since 1905. Browse on your own, or explore our curated collections and timely recommendations.WATCH THIS VIDEO for highlights of everything the Maclean's Archives has to offer.